COMMUNIQUÉS West-GlobeNewswire

Abattis Strengthens Management Team and Provides Company Updates

11/09/2018 - 13:00

VANCOUVER, British Columbia, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis ”) ( CSE:ATT ) ( OTC:ATTBF ) is pleased to provide the following corporate updates. The Company is [...]

Auxly and Lotus Ventures Announce Investment and Signing of Definitive Long Term Purchase and Sale Agreement

11/09/2018 - 13:00

VANCOUVER, British Columbia, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) (" Auxly " or the " Company ") and Lotus Ventures Inc. ( CSE – J )(“ Lotus ”) are pleased to [...]

Nu-Med Plus, Inc. Announces Prominent Research Lab to Utilize its New Advanced Nitric Oxide Delivery Product for Study

11/09/2018 - 13:00

Choice of Nu-Med Plus 100 unit provides researchers the first-ever nitric oxide dilution system purpose-built for research SALT LAKE CITY, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD), a medical [...]

Easton Pharmaceuticals Announces It Has Entered Into High Level Negotiations To Take Over a Profitable Hotel and a $17,000,000 Real Estate Asset Located In The Heart of Toronto, Ontario, Canada

11/09/2018 - 13:00

TORONTO, ON , Sept. 11, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Easton Pharmaceuticals Inc. (OTC: EAPH) is pleased to announce that it has entered into high level negotiations to take over an operating boutique [...]

ChromaDex to Participate in “Conquering Aging” Briefing with Frost & Sullivan

11/09/2018 - 12:30

Frank Jaksch, ChromaDex Co-Founder & Executive Chairman, to discuss nutraceuticals, aging, and NAD IRVINE, Calif., Sept. 11, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, [...]

iKang Schedules 2018 Unaudited First Quarter Earnings Release on September 27, 2018

11/09/2018 - 12:00

BEIJING, Sept. 11, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]

Allscripts appointed to Health Systems Support Framework

11/09/2018 - 09:00

EPR and shared care record provider secures place on NHS England framework that will give health and care organisations easier, faster access to new technology MANCHESTER, United Kingdom, Sept. 11, 2018 (GLOBE NEWSWIRE [...]

Solon Eiendom ASA – Primary insider notification

11/09/2018 - 08:30

(Oslo, Norway, September 10, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Dukat AS bought 35.000 shares in Solon Eiendom ASA at a price of NOK 29.0293. Following [...]

Shire plc: Rule 2.9 Announcement

11/09/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 11 September 2018 [...]

NEOVACS ANNOUNCES THAT ITS PARTNER BIOSENSE GLOBAL HAS EXERCISED ITS OPTION TO ACQUIRE THE EXCLUSIVE LICENCE FOR IFNalpha KINOID TO TREAT LUPUS IN CHINA

11/09/2018 - 07:02

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES THAT ITS PARTNER BIOSENSE GLOBAL HAS EXERCISED ITS OPTION TO ACQUIRE THE EXCLUSIVE LICENCE FOR IFNalpha KINOID TO TREAT LUPUS IN CHINA Paris and Boston, 11 [...]

NÉOVACS ANNONCE LA LEVÉE DE L'OPTION DE LICENCE SIGNÉE AVEC BIOSENSE GLOBAL POUR LE DÉVELOPPEMENT EN CHINE DE L'IFNalpha KINOIDE DANS LE LUPUS

11/09/2018 - 07:02

COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS ANNONCE LA LEVÉE DE L'OPTION DE LICENCE SIGNÉE AVEC BIOSENSE GLOBAL POUR LE DÉVELOPPEMENT EN CHINE DE L'IFNalpha KINOIDE DANS LE TRAITEMENT DU [...]

Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis

11/09/2018 - 07:01

Global headquarters to be co-located in Geneva alongside Alcon's Europe, Middle East and Africa regional office The listed Alcon company will be incorporated in Fribourg, where Alcon already has significant operations, [...]

Biocartis Group NV: Biocartis Creates New Warrant Plan

11/09/2018 - 07:01

PRESS RELEASE : REGULATED INFORMATION Tuesday, 11 September 2018, 07:00 CEST Biocartis Creates New Warrant Plan Mechelen, Belgium, 11 September 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]

Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 Program

11/09/2018 - 03:17

BURNABY, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused biopharmaceutical company, today announced it has signed an agreement with [...]

CV Sciences, Inc. Achieves Industry’s First Hemp Extract GRAS Self-Affirmation

11/09/2018 - 01:33

First Hemp Extract to Achieve Highly Sought-After Self-Affirmed GRAS Status Designation LAS VEGAS, Sept. 10, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) [...]

Telix Completes Acquisition of Atlab for Prostate Cancer Program

11/09/2018 - 01:30

MELBOURNE, Australia and NANTES, France, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) today announced completion of the acquisition of Atlab Pharma SAS (“Atlab”). The option [...]

North Dakota’s first all-ages free dental care event coming to Bismarck

11/09/2018 - 00:09

Hundreds of volunteers to provide free dental services during Mission of Mercy at Bismarck Event Center, Sept. 28-29 BISMARCK, N.D., Sept. 10, 2018 (GLOBE NEWSWIRE) -- The North Dakota Dental Association and North [...]

SIGA Technologies Awarded BARDA Contract for TPOXX®

10/09/2018 - 23:50

- Contract Valued at Up to $629 Million – - Contract Includes Delivery of Oral and Intravenous (IV) Formulations of TPOXX; Development of IV TPOXX; Post-marketing Activities – NEW YORK, Sept. 10, 2018 (GLOBE NEWSWIRE [...]

BioSyent Announces Changes to Executive Management

10/09/2018 - 23:28

TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) today announced changes to its Executive Management team: Effective on September 10, 2018, Mr. Alfred D’Souza has [...]